Sun Pharma, Grünenthal Are Said to Vie for US-Listed Organon
Sun Pharmaceutical Industries Ltd. and Germany’s Grünenthal are among firms vying for New York-listed women’s health-care company Organon & Co., according to people familiar with the matter.
Original Source
Read the full article at Bloomberg →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.